![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Clinical outcomes of once-daily darunavir in treatment-experienced patients with
darunavir resistance associated mutations through 48 weeks of treatment
|
|
|
IDWeek, October 2-6, 2019, Washington, DC
Reported by Jules Levin
Charlotte-Paige Rolle MD MPH1, 2; Omar Marquez LPN CRC1;Vu Nguyen MS3; Federico HinestrosaMD1,3; Edwin DeJesusMD1,3
1Orlando Immunology Center, Orlando, FL, USA, 2 Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, USA, 3University of Central Florida College of Medicine, Orlando, FL, USA
![1021191](../images/102119/102119-3/1021191.gif)
![1021192](../images/102119/102119-3/1021192.gif)
![1021193](../images/102119/102119-3/1021193.gif)
![1021194](../images/102119/102119-3/1021194.gif)
![1021195](../images/102119/102119-3/1021195.gif)
![1021196](../images/102119/102119-3/1021196.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|